Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study	THE AMERICAN JOURNAL OF MEDICINE	2019
A Simple Clinical Risk Score (C 2 HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects	CHEST	2019
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort	ATHEROSCLEROSIS	2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease	LIVER INTERNATIONAL	2019
Statins and non-alcoholic fatty liver disease	LIVER INTERNATIONAL	2019
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?	WORLD JOURNAL OF GASTROENTEROLOGY	2019
Off-label use of ceftaroline fosamil: a systematic review	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2019
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation	MAYO CLINIC PROCEEDINGS	2019
Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion?	ANTIOXIDANTS & REDOX SIGNALING	2019
Left atrium dilatation and left ventricular hypertrophy predispose to atrial fibrillation in patients with community-acquired pneumonia	THE AMERICAN JOURNAL OF CARDIOLOGY	2019
Multiple arterial thrombosis in seronegative antiphospholipid syndrome. need for new diagnostic criteria	EUROPEAN JOURNAL OF CASE REPORTS IN INTERNAL MEDICINE	2019
Thrombocytopenia and mortality risk in patients with atrial fibrillation. an analysis from the START registry	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2019
Anticoagulants in atrial fibrillation and liver disease	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2019
Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs. results from the prospective multicenter START2-register study	THROMBOSIS RESEARCH	2019
Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation	INTERNAL AND EMERGENCY MEDICINE	2019
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)	THE AMERICAN JOURNAL OF CARDIOLOGY	2019
Overexpression of the vitronectin v10 subunit in patients with nonalcoholic steatohepatitis: Implications for noninvasive diagnosis of NASH	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2018
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque	SCIENTIFIC REPORTS	2018
Severity of OSAS, CPAP and cardiovascular events: a follow-up study	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2018
Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome	SLEEP MEDICINE	2018

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.